Home Overview Press Room Blog Publications For Students about us
Search

About Biopolitics, Parties, Pundits & Human Biotechnology


Policy decisions about human biotechnologies have typically been debated among elite commissions and experts. But controversy is increasingly spilling over into mainstream news media and political debates.

This trend has been most notable in the United States, with the emergence of human embryonic stem cell research as a political issue. Stem cell debates at the policy level have made this discussion far more visible to the public.

The Bush Administration's restrictions on federal funding for human embryonic stem cell research elevated the issue to the front pages of newspapers. Shortly after its announcement in 2001, partisan battle lines were drawn in ways that mirror the abortion rights divide.

Republicans hoped that opposition to research that destroys embryos would increase support among their party's religious conservative base. Democrats countered by assembling a coalition of patient advocates, biomedical researchers, and biotechnology entrepreneurs and appealed to moderate swing voters and Republicans who they believed would be swayed by promises of cures.

There were some notable exceptions to this partisan line-up. Some conservatives support embryonic stem cell research; some liberals and progressives who support the research in principle criticize aspects of its conduct and regulation. Unfortunately, the polarized debate has frequently distorted facts while obscuring a range of important social issues unrelated to the moral status of embryos.



Biopolitical News of 2014by Pete Shanks, Jessica Cussins & Marcy DarnovskyBiopolitical TimesDecember 18th, 2014This is everything important that happened in biopolitics in 2014 (or close to it).
European Court Opens Door for Stem Cell PatentingGenetic Engineering & Biotechnology NewsDecember 18th, 2014The European Court of Justice ruled that human embryonic stem cell patents could be allowed if organisms can't develop into human being.
Top Biopolitical Times Posts of 2014by Jessica Cussins & Pete ShanksBiopolitical TimesDecember 18th, 2014In 2014, CGS staffers and contributors posted 107 blogs in Biopolitical Times. These are twelve of our favorites.
Geneticists Begin Tests of an Internet for DNAby Antonio RegaladoMIT Technology ReviewDecember 17th, 2014Scientists are starting to open their DNA databases online, creating a network that could pave the way for gene analysis at a new scale.
Myriad Loses Appeals Court Bid to Block Breast Cancer Testsby Susan DeckerBloomberg BusinessweekDecember 17th, 2014Myriad Genetics can’t block competitors’ DNA tests to determine risk for breast and ovarian cancer after a US appeals court said three patents on the tests never should have been issued.
Yesterday's War; Tomorrow's Technology by Nicholas G. Evans and Jonathan D. MorenoJournal of Law and the BiosciencesDecember 15th, 2014What's wrong with the prospect of the US military using genetic screening and germline genetic engineering to select or "enhance" soldiers?
Taking your Genome to the Bankby Harry GlorikianGenetic Engineering & Biotechnology NewsDecember 15th, 2014Your genome has huge implications for you and your children. Institutions that store it should be regulated on how they store it, use it, and potentially share it.
The ‘Science’ of Eugenics: America’s Moral Detourby Marilyn M. SingletonJournal of American Physicians and SurgeonsDecember 15th, 2014Within 100 years, our deep thinkers went from declaring that in our new country “all men are created equal” to espousing the idea that “some men are more equal than others.”
Genetic Discrimination Means the Choice Between Life and Life Insuranceby Shimon Koffler Fogel and Bev Heim-MyersHuffington Post [Canada]December 12th, 2014Unfortunately, Canadians across the country currently face real as well as potential future discrimination based on their DNA.
CRISPR Opportunities ... For What? And for Whom?by Pete ShanksHuffington PostDecember 10th, 2014Money and deals are flowing into companies that promise to edit genes. Human, animal, plant, all kinds of DNA may be on the cutting board.
Displaying 1-10 of 727  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760